|
|
Gene Symbol |
GIP |
|
Aliases |
- |
|
Entrez Gene ID |
|
|
Gene Name |
Gastric inhibitory polypeptide |
|
Chromosomal Location |
17q21.32 |
|
HGNC ID |
|
|
Summary |
This gene encodes an incretin hormone and belongs to the glucagon superfamily. The encoded protein is important in maintaining glucose homeostasis as it is a potent stimulator of insulin secretion from pancreatic beta-cells following food ingestion and nutrient absorption. This gene stimulates insulin secretion via its G protein-coupled receptor activation of adenylyl cyclase and other signal transduction pathways. It is a relatively poor inhibitor of gastric acid secretion. [provided by RefSeq, Jul 2008]
|
|
e!Ensembl
|
Protein Information |
|
Protein Name |
Gastric inhibitory polypeptide, glucose-dependent insulinotropic polypeptide, incretin hormone |
|
Function |
Potent stimulator of insulin secretion and relatively poor inhibitor of gastric acid secretion |
|
|
UniProt |
|
|
PDB |
|
|
Pfam |
Pfam Accession |
Pfam ID |
PF00123 |
Hormone_2 |
|
|
|
|
Interactions |
| |
STRING |
MINT |
IntAct |
ENSP00000257863 |
|
Q16671 |
|
| |
View interactions
|
|
| |
Associated Diseases
Disease group | Disease Name | References |
Cardiovascular Diseases |
Arteriosclerosis |
|
Endocrine System Diseases |
PCOS |
|
|
References |
|
|
|
PubMed ID |
Associated gene/s |
Associated condition |
Genetic Mutation |
Diagnostic Criteria |
Association with PCOS |
Ethnicity |
Conclusion |
|
GLP-1,C-peptide |
Insulin resistance,type 2 diabetes |
|
|
Related
|
|
Increased insulinotropic effect could counteract the blunted GIP response to OGTT in obese women with PCOS. |
|
GLP-1,C-peptide |
Type 2 diabetes |
|
|
Related
|
|
Increased total GIP and lower late phase active GLP-1 concentrations during OGTT characterize PCOS women with higher C-peptide secretion in comparison with healthy controls, and may be the early markers of a pre-diabetic state. |
|
|
|
|